Andrew Lo

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Will Solis, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew Lo:

Company Role Class Num Shares Value Price $ Report Date Ownership
BridgeBio Pharma, Inc. Director Common Stock 50,583 $3,340,956 $66.05 18 Nov 2025 By Andrew W. Lo and Nancy N. Lo JTWROS
BridgeBio Pharma, Inc. Director Common Stock 14,089 $944,751 $67.06 17 Nov 2025 Direct
Roivant Sciences Ltd. Director Common Shares 52,142 $539,670 $10.35 15 Sep 2022 Direct
AbCellera Biologics Inc. Director Share option (right to buy) 541,354 12 Jun 2025 Direct
Roivant Sciences Ltd. Director Stock Option (Right to Buy) 71,850 15 Sep 2022 Direct
BridgeBio Pharma, Inc. Director Stock Option (Right to Buy) 8,425 20 Jun 2025 Direct

Insider Reports Filed by Andrew Lo

Symbol Company Period Transactions Value $ Form Type Role Filing Time
BBIO BridgeBio Pharma, Inc. 17 Nov 2025 4 -$6,319,662 4 Director 19 Nov 2025, 17:08
BBIO BridgeBio Pharma, Inc. 20 Jun 2025 2 $0 4 Director 24 Jun 2025, 19:13
ABCL AbCellera Biologics Inc. 12 Jun 2025 1 $0 4 Director 16 Jun 2025, 17:30
BBIO BridgeBio Pharma, Inc. 02 May 2025 1 -$3,849,900 4 Director 06 May 2025, 16:42
BBIO BridgeBio Pharma, Inc. 21 Jun 2024 1 $0 4 Director 25 Jun 2024, 17:38
ABCL AbCellera Biologics Inc. 21 Jun 2024 1 $0 4 Director 24 Jun 2024, 18:19
BBIO BridgeBio Pharma, Inc. 21 Jun 2023 1 $0 4 Director 23 Jun 2023, 16:21
ABCL AbCellera Biologics Inc. 01 Dec 2022 1 $0 4 Director 05 Dec 2022, 11:34
ROIV Roivant Sciences Ltd. 15 Sep 2022 2 $0 4 Director 19 Sep 2022, 21:53
BBIO BridgeBio Pharma, Inc. 22 Jun 2022 1 $0 4 Director 24 Jun 2022, 16:31
BBIO BridgeBio Pharma, Inc. 29 Dec 2021 2 +$98,850 4 Director 03 Jan 2022, 18:57
ABCL AbCellera Biologics Inc. 03 Dec 2021 1 $0 4/A Director 10 Dec 2021, 13:36
ABCL AbCellera Biologics Inc. 03 Dec 2021 0 $0 3 Director 07 Dec 2021, 14:16
ROIV Roivant Sciences Ltd. 01 Oct 2021 0 $0 3 Director 01 Oct 2021, 17:39
BBIO BridgeBio Pharma, Inc. 17 Jun 2021 1 $0 4 Director 22 Jun 2021, 19:38